CORBION NV (CRBN.AS) Stock Fundamental Analysis
AMS:CRBN - Euronext Amsterdam - NL0010583399 - Common Stock - Currency: EUR
CRBN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 67 industry peers in the Chemicals industry. CRBN has an excellent profitability rating, but there are some minor concerns on its financial health. CRBN scores decently on growth, while it is valued quite cheap. This could make an interesting combination. This makes CRBN very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year CRBN was profitable.
In the past year CRBN had a positive cash flow from operations.
In the past 5 years CRBN has always been profitable.
CRBN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 12.43%, CRBN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CRBN has a better Return On Equity (24.88%) than 98.51% of its industry peers.
CRBN has a better Return On Invested Capital (6.89%) than 71.64% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRBN is in line with the industry average of 6.51%.
The last Return On Invested Capital (6.89%) for CRBN is above the 3 year average (6.62%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.43% | ||
| ROE | 24.88% | ||
| ROIC | 6.89% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
1.3 Margins
The Profit Margin of CRBN (14.92%) is better than 95.52% of its industry peers.
In the last couple of years the Profit Margin of CRBN has grown nicely.
Looking at the Operating Margin, with a value of 7.04%, CRBN is in line with its industry, outperforming 58.21% of the companies in the same industry.
In the last couple of years the Operating Margin of CRBN has declined.
CRBN has a Gross Margin of 24.81%. This is in the lower half of the industry: CRBN underperforms 61.19% of its industry peers.
CRBN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.04% | ||
| PM (TTM) | 14.92% | ||
| GM | 24.81% |
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRBN is still creating some value.
Compared to 1 year ago, CRBN has less shares outstanding
The number of shares outstanding for CRBN has been reduced compared to 5 years ago.
The debt/assets ratio for CRBN has been reduced compared to a year ago.
2.2 Solvency
CRBN has an Altman-Z score of 2.55. This is not the best score and indicates that CRBN is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.55, CRBN is in the better half of the industry, outperforming 64.18% of the companies in the same industry.
CRBN has a debt to FCF ratio of 5.10. This is a neutral value as CRBN would need 5.10 years to pay back of all of its debts.
CRBN has a better Debt to FCF ratio (5.10) than 71.64% of its industry peers.
CRBN has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
CRBN has a Debt to Equity ratio (0.40) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | 5.1 | ||
| Altman-Z | 2.55 |
ROIC/WACC1.09
WACC6.32%
2.3 Liquidity
A Current Ratio of 1.17 indicates that CRBN should not have too much problems paying its short term obligations.
CRBN's Current ratio of 1.17 is on the low side compared to the rest of the industry. CRBN is outperformed by 77.61% of its industry peers.
CRBN has a Quick Ratio of 1.17. This is a bad value and indicates that CRBN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CRBN (0.58) is worse than 88.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.17 | ||
| Quick Ratio | 0.58 |
3. Growth
3.1 Past
CRBN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 168.39%, which is quite impressive.
CRBN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 49.47% yearly.
CRBN shows a small growth in Revenue. In the last year, the Revenue has grown by 1.90%.
The Revenue has been growing slightly by 5.70% on average over the past years.
EPS 1Y (TTM)168.39%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-47.64%
Revenue 1Y (TTM)1.9%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%4.6%
3.2 Future
Based on estimates for the next years, CRBN will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.90% on average per year.
Based on estimates for the next years, CRBN will show a decrease in Revenue. The Revenue will decrease by -0.61% on average per year.
EPS Next Y55.4%
EPS Next 2Y34.31%
EPS Next 3Y27.5%
EPS Next 5Y12.9%
Revenue Next Year1.65%
Revenue Next 2Y2.7%
Revenue Next 3Y3.27%
Revenue Next 5Y-0.61%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 5.71, which indicates a rather cheap valuation of CRBN.
Based on the Price/Earnings ratio, CRBN is valued cheaper than 98.51% of the companies in the same industry.
CRBN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.28.
CRBN is valuated reasonably with a Price/Forward Earnings ratio of 11.87.
Based on the Price/Forward Earnings ratio, CRBN is valued a bit cheaper than the industry average as 76.12% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CRBN to the average of the S&P500 Index (21.76), we can say CRBN is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.71 | ||
| Fwd PE | 11.87 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRBN indicates a somewhat cheap valuation: CRBN is cheaper than 67.16% of the companies listed in the same industry.
85.07% of the companies in the same industry are more expensive than CRBN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.82 | ||
| EV/EBITDA | 8.64 |
4.3 Compensation for Growth
CRBN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRBN has a very decent profitability rating, which may justify a higher PE ratio.
CRBN's earnings are expected to grow with 27.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.1
PEG (5Y)0.12
EPS Next 2Y34.31%
EPS Next 3Y27.5%
5. Dividend
5.1 Amount
CRBN has a Yearly Dividend Yield of 3.50%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.08, CRBN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.42, CRBN pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
5.2 History
The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
5.3 Sustainability
21.80% of the earnings are spent on dividend by CRBN. This is a low number and sustainable payout ratio.
The dividend of CRBN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP21.8%
EPS Next 2Y34.31%
EPS Next 3Y27.5%
AMS:CRBN (7/2/2025, 7:00:00 PM)
18.56
+0.12 (+0.65%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners75.76%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.08B
Analysts76.92
Price Target25.92 (39.66%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP21.8%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.61%
PT rev (3m)-6.37%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.41%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.71 | ||
| Fwd PE | 11.87 | ||
| P/S | 0.84 | ||
| P/FCF | 10.82 | ||
| P/OCF | 5.87 | ||
| P/B | 1.4 | ||
| P/tB | 1.61 | ||
| EV/EBITDA | 8.64 |
EPS(TTM)3.25
EY17.51%
EPS(NY)1.56
Fwd EY8.43%
FCF(TTM)1.72
FCFY9.24%
OCF(TTM)3.16
OCFY17.03%
SpS22.11
BVpS13.26
TBVpS11.56
PEG (NY)0.1
PEG (5Y)0.12
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.43% | ||
| ROE | 24.88% | ||
| ROCE | 8.18% | ||
| ROIC | 6.89% | ||
| ROICexc | 7.21% | ||
| ROICexgc | 7.95% | ||
| OM | 7.04% | ||
| PM (TTM) | 14.92% | ||
| GM | 24.81% | ||
| FCFM | 7.76% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexcg growth 3Y0.82%
ROICexcg growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score8
Asset Turnover0.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | 5.1 | ||
| Debt/EBITDA | 1.73 | ||
| Cap/Depr | 97% | ||
| Cap/Sales | 6.54% | ||
| Interest Coverage | 3.61 | ||
| Cash Conversion | 103.72% | ||
| Profit Quality | 51.98% | ||
| Current Ratio | 1.17 | ||
| Quick Ratio | 0.58 | ||
| Altman-Z | 2.55 |
F-Score8
WACC6.32%
ROIC/WACC1.09
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)168.39%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-47.64%
EPS Next Y55.4%
EPS Next 2Y34.31%
EPS Next 3Y27.5%
EPS Next 5Y12.9%
Revenue 1Y (TTM)1.9%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%4.6%
Revenue Next Year1.65%
Revenue Next 2Y2.7%
Revenue Next 3Y3.27%
Revenue Next 5Y-0.61%
EBIT growth 1Y44.66%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year139.88%
EBIT Next 3Y39.25%
EBIT Next 5Y24.55%
FCF growth 1Y520.5%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y11.31%
OCF growth 3Y101.81%
OCF growth 5Y9.98%